Delivery Order SPE2DB20D3103-SPE2DB22FL8B2
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,739.44 firm fixed-price delivery order is for the supply of 20,000 unit vials of Thrombin-JMI, a specialized blood coagulant product. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. The...
- This federal contract award, with ID SPE2DX15D2223|SPE2DX24F4GAN, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,805.10 firm fixed price delivery order is for the supply of 5,000 unit vials of Thrombin-JMI, a specialty pharmaceutical product. The contract has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Thrombin-JMI 20,000 unit vials valued at $1,550.51. This firm fixed-price delivery order, with an ultimate completion date of October 31, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of 5,000 unit vials of Thrombin-JMI, a specialty pharmaceutical product, with a potential value of $1,615.50. The contract has a completion date of March 6, 2024 and was awarded on March 5, 2024. No set-aside designation was...
- This contract award is for the delivery of 20,000 unit vials of THROMBIN-JMI to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is a firm fixed price delivery order with a potential value of $2,061.15. The place of performance is Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. This award is not associated...
- The Defense Logistics Agency awarded a delivery order valued at $1,009.40 to AmerisourceBergen Drug Corp for Thrombin USP Bovine on December 12, 2025, with an ultimate completion date of December 15, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order represents a child contract under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distribution company. The $5,575.17 firm fixed-price delivery order is for the supply of 20,000 unit vials of the medical product RECOTHROM. This order falls under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,139.43 Firm Fixed Price contract is for the delivery of 20,000 unit vials of the specialty medication RECOTHROM. This award is a Delivery Order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,513.82 fixed-price delivery order is for the supply of 20,000 unit vials of RECOTHROM, a specialty medication. The contract has a period of performance through December 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $36,065.78 firm-fixed-price delivery order is for the supply of 20,000 unit vials of RECOTHROM, a pharmaceutical product. The contract has a completion date of July 30, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, leveraging its extensive supply chain...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FL8B2Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,765.48 firm fixed-price delivery order is for the supply of 20,000-unit vials of the drug Thrombin-JMI. The contract has an ultimate completion date of November 30, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 11/29/21 |